ABICAP
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

ABICAP Trademark

Serial Number: 75208771 • Registration: 2229905

ABICAP is a trademark filed by ABION BETEILIGUNGS- UND VERWALTUNGSGESELLSCHAFT MBH on December 5, 1996. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 16 (Paper Goods). The application is currently no longer active.

Owner Contact Info

ABION BETEILIGUNGS- UND VERWALTUNGSGESELLSCHAFT MBH (2 trademarks)

Karl-Heinz-Beckurts-Strasse 13
Julich D-52428 , DE

Entity Type: 99

Trademark Details

Filing Date

December 5, 1996

Registration Date

March 9, 1999

Published for Opposition

December 15, 1998

Cancellation Date

December 17, 2005

Goods & Services

publication of text books for scientific instruction

scientific apparatus and instruments, namely, chromatographic columns sold empty or filled with materials for bioassays, medical assays or immunoassays for scientific research use; laboratory equipment, namely, syringes; hollow bodies having several separated chambers for storing and releasing assay reagents; electric apparatus, namely, robots for automatically performing assay steps, such as gripping of columns, pipetting and dosage of test reagents and samples; detectors, namely, photometers, detectors for measuring weight, magnetism, light scattering, density, light intensity, light wavelength, luminescence, luminous flux, illumination, brightness, electrical signals, electromagnetic energy, number of particles, size of particles, density, or gravimetric properties for use in scientific research and analytical investigations; computer software for use in performing and evaluating diagnostic tests in the field of detection of various disease stages and disease stage metabolites

medical diagnostic test kits consisting primarily of reagents for use in detecting different illness stages or metabolites indicating a particular illness stage; medical diagnostic immunoanalytic test kits consisting primarily of immunoreagents, namely, antibodies and antigens for detecting and assaying biochemical or organic substances

printed matter, namely, newsletters, textbooks, brochures, magazines, manuals in the field of promotion, information, training, research, user instructions, each in the field of assay technology

chemicals and biochemicals used in industry and science, namely, test kits consisting primarily of reagents for the detection of various disease stages and diesease stage metabolites, for research and analytical use in environmental engineering, medicine and biotechnology; material for performing bioassays, namely, particulate and fibrous materials, namely, inorganic and organic polymer-based matrices in bulk, gel or molded form for use in test kits comprising primarily reagents for the detection of various disease stages and disease stage metabolites sold separately and as the primary component of test kits for research use and analytical investigation; research test kits consisting primarily of reagents for use in detecting different illness stages or metabolites indicating a particular illness stage; immunoanalytic test kits consisting primarily of immunoreagents, namely, antibodies and antigens for assaying and detecting substances; all the above also for monitoring of biochemical production and environmental analysis and food analysis

medical diagnostic test kits consisting primarily of columns, reagents or immunoreagents in aqueous solutions or in lyophilized form for use in detecting different illness stages or metabolites indicating a particular illness stage; medical diagnostic apparatus for detecting different illness stages or metabolites indicating a particular illness stage; medical diagnostic apparatus for in vitro examinations for the treatment or diagnosis of a specific disease or condition; cannulas; medical syringes, hollow bodies having several separated chambers for storing and releasing assay reagents for medical diagnostic use, electric apparatus, namely, robots for performing automatically assay steps, such as gripping of columns, pipetting and dosage of test reagents and samples for medical diagnostic use; detectors, namely, photometers, detectors for measuring weight, magnetism, light scattering, density, light intensity, light wavelength, luminescence, luminous flux, illumination, brightness, electrical signals, electromagnetic energy, number of particles, size of particles, density, or gravimetric properties for medical diagnostic use

laboratory research in the field of assay technology

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 17, 2005 C8..
REGISTERED-PRINCIPAL REGISTER
Mar 9, 1999 R.PR
PUBLISHED FOR OPPOSITION
Dec 15, 1998 PUBO
NOTICE OF PUBLICATION
Nov 13, 1998 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 3, 1998 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 24, 1998 CRFA
FINAL REFUSAL MAILED
Feb 24, 1998 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 24, 1997 CRFA
Sec. 1(B) CLAIM DELETED
Dec 24, 1997 1.BD
NON-FINAL ACTION MAILED
Jun 26, 1997 CNRT
ASSIGNED TO EXAMINER
Jun 25, 1997 DOCK